NYSE: BCSSBain Capital Gss Investment Corp Stock
$10.11+0.01 (+0.1%)
Updated Apr 7, 2026
BCSS Price
$10.11
Fair Value Price
N/A
Market Cap
$590.42M
52 Week Low
$9.95
52 Week High
$10.33
P/E
59.47x
P/B
-38.85x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$4.26M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.08
Operating Cash Flow
-$543k
Beta
0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BCSS's potential to beat the market
- BCSS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
BCSS
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.59 | C | |
| $10.71 | C | |
| $10.96 | C |
Be the first to know about important BCSS news, forecast changes, insider trades & much more!
BCSS News
Overview
Due Diligence Score
–
Industry Average (10)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BCSS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BCSS is poor value based on its earnings relative to its share price (59.47x), compared to the US market average (29.87x)
P/E vs Market Valuation
BCSS is good value based on its earnings relative to its share price (59.47x), compared to the US Shell Companies industry average (-60.35x)
P/E vs Industry Valuation
BCSS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more BCSS due diligence checks available for Premium users.
Valuation
BCSS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
59.47x
Industry
-60.35x
Market
29.87x
BCSS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BCSS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
BCSS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-38.85x
Industry
30.07x
BCSS's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
BCSS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$465.8M
Liabilities
$16.4M
Debt to equity
-1.08
BCSS's short-term assets ($1.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BCSS's long-term liabilities ($16.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BCSS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BCSS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
BCSS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BCSS vs Shell Company Stocks
Bain Capital Gss Investment Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.